A Computational Assay of Estrogen Receptor α Antagonists Reveals the Key Common Structural Traits of Drugs Effectively Fighting Refractory Breast CancersMatic Pavlin, Alessandra Magistrato, Giorgio Colombo et al.|Scientific Reports|2018Cited by 64
Rational design of allosteric modulators of the aromatase enzyme: An unprecedented therapeutic strategy to fight breast cancerAngelo Spinello, Alessandra Magistrato, Silvia Martini et al.|European Journal of Medicinal Chemistry|2019Cited by 37
Balanced dual acting compounds targeting aromatase and estrogen receptor α as an emerging therapeutic opportunity to counteract estrogen responsive breast cancerJessica Caciolla, Alessandra Magistrato, Silvia Gobbi et al.|European Journal of Medicinal Chemistry|2021Cited by 23